These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6342655)

  • 1. Cyclosporin A associated nephrotoxicity in the first 100 days after allogeneic bone marrow transplantation: three distinct syndromes.
    Atkinson K; Biggs JC; Hayes J; Ralston M; Dodds AJ; Concannon AJ; Naidoo D
    Br J Haematol; 1983 May; 54(1):59-67. PubMed ID: 6342655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nephrotoxicity in bone marrow transplant recipients treated with cyclosporin A.
    Hows JM; Chipping PM; Fairhead S; Smith J; Baughan A; Gordon-Smith EC
    Br J Haematol; 1983 May; 54(1):69-78. PubMed ID: 6342656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporin A in marrow transplantation for leukemia and aplastic anemia.
    Bacigalupo A; Frassoni F; van Lint MT; Raffo MR; Vitale V; Corbetta G; Chierichetti S; Marmont AM
    Exp Hematol; 1985 May; 13(4):244-8. PubMed ID: 3886417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marrow transplant experience for children with severe aplastic anemia.
    Sanders JE; Storb R; Anasetti C; Deeg HJ; Doney K; Sullivan KM; Witherspoon RP; Hansen J
    Am J Pediatr Hematol Oncol; 1994 Feb; 16(1):43-9. PubMed ID: 8311172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporin A serum and blood levels in marrow graft recipients: correlation with administered dose, serum creatinine and graft-versus-host disease.
    Bacigalupo A; Di Giorgio F; Frassoni F; Van Lint MT; Raffo MR; Gogioso L; Viale M; Marmont AM
    Acta Haematol; 1984; 72(3):155-62. PubMed ID: 6438979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral administration of cyclosporin A for recipients of allogeneic marrow transplants: implications of clinical gut dysfunction.
    Atkinson K; Biggs JC; Britton K; Short R; Mrongovius R; Concannon A; Dodds A
    Br J Haematol; 1984 Feb; 56(2):223-31. PubMed ID: 6362711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of cyclosporin A in allogeneic bone marrow transplantation for severe aplastic anemia.
    Hows JM; Palmer S; Gordon-Smith EC
    Transplantation; 1982 Apr; 33(4):382-6. PubMed ID: 7041363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow transplantation in 33 patients with malignant blood diseases and severe aplastic anaemia.
    Biggs J; Atkinson K; Concannon A; Dodds A; Harkness J; Yuile P; Causer P; Bashir H; Penny R; Nicholls M; Ting A; Pun A; Honeyman M
    Med J Aust; 1983 Aug; 2(3):120-5. PubMed ID: 6348501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bone marrow transplantation in leukemia and aplastic anemia].
    Speck B; Gratwohl A; Nissen C; Osterwalder B; Signer E; Jeannet M
    Schweiz Med Wochenschr; 1983 Apr; 113(17):622-9. PubMed ID: 6346483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppression with cyclosporin A in allogeneic bone marrow transplantation for severe aplastic anaemia: preliminary studies.
    Hows J; Harris R; Palmer S; Gordon-Smith EC
    Br J Haematol; 1981 Jun; 48(2):227-36. PubMed ID: 7016166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized trial comparing use of cyclosporin and methotrexate for graft-versus-host disease prophylaxis in bone marrow transplant recipients with haematological malignancies.
    Ringdén O; Bäckman L; Lönnqvist B; Heimdahl A; Lindholm A; Bolme P; Gahrton G
    Bone Marrow Transplant; 1986 May; 1(1):41-51. PubMed ID: 3332119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporine combined with methylprednisolone or methotrexate in prophylaxis of moderate to severe acute graft-versus-host disease.
    Gondo H; Harada M; Taniguchi S; Akashi K; Hayashi S; Teshima T; Takamatsu Y; Eto T; Nagafuji K; Yamasaki K
    Bone Marrow Transplant; 1993 Nov; 12(5):437-41. PubMed ID: 8298553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporin A following matched and mismatched family allogeneic bone marrow transplants.
    Powles RL; Morgenstern GR; Leigh M; Filshie J; Platt J; Lumley H
    Haematol Blood Transfus; 1983; 28():87-9. PubMed ID: 6345298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graft-versus-host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia: long-term follow-up of a controlled trial.
    Storb R; Deeg HJ; Pepe M; Doney K; Appelbaum F; Beatty P; Bensinger W; Buckner CD; Clift R; Hansen J
    Br J Haematol; 1989 Aug; 72(4):567-72. PubMed ID: 2673331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Graft-versus-host disease prophylaxis with anti-T-cell monoclonal antibody OKT3, prednisone and methotrexate in allogeneic bone-marrow transplantation.
    Filipovich AH; Krawczak CL; Kersey JH; McGlave P; Ramsay NK; Goldman A; Goldstein G
    Br J Haematol; 1985 May; 60(1):143-52. PubMed ID: 3890926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombotic thrombocytopenic purpura: a rare late complication of allogeneic bone marrow transplantation.
    Pucci G; Martino M; Morabito F; Iacopino P; Arcese W; Iori AP; Lombardo VT; L'Abbate A; Santostefano M; Nobile F
    Haematologica; 1994; 79(4):371-3. PubMed ID: 7806094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recipients of HLA-identical sibling marrow transplants with severe aplastic anemia engraft more quickly, and those with chronic myeloid leukemia more slowly, than those with acute leukemia.
    Atkinson K; Downs K; Ashby M; Dodds A; Concannon A; Biggs J
    Bone Marrow Transplant; 1989 Jan; 4(1):23-7. PubMed ID: 2647183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of cyclosporin and methotrexate for prophylaxis of acute graft-versus-host disease after allogeneic bone marrow transplantation for leukemia.
    Mrsić M; Labar B; Bogdanić V; Nemet D; Pavletić Z; Plavsić F; Dobrić I; Marusić M; Francetić I; Kastelan A
    Bone Marrow Transplant; 1990 Aug; 6(2):137-41. PubMed ID: 2207450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporin-A in allogeneic bone marrow transplantation for leukemia: Basle experience 1979 to 1984.
    Gratwohl A
    Tokai J Exp Clin Med; 1985 Jun; 10(2-3):127-32. PubMed ID: 3914737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephrotoxicity of cyclosporin A after allogeneic marrow transplantation: glomerular thromboses and tubular injury.
    Shulman H; Striker G; Deeg HJ; Kennedy M; Storb R; Thomas ED
    N Engl J Med; 1981 Dec; 305(23):1392-5. PubMed ID: 7029278
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.